tradingkey.logo

Cytomx Therapeutics Announces Business Update And Company Milestones For 2026

ReutersJan 8, 2026 1:32 PM

- CytomX Therapeutics Inc CTMX.O:

  • CYTOMX THERAPEUTICS ANNOUNCES BUSINESS UPDATE AND COMPANY MILESTONES FOR 2026

  • CYTOMX THERAPEUTICS INC - CX-2051 PHASE 1 DATA ON TRACK FOR Q1 2026

  • CYTOMX THERAPEUTICS: INITIAL CX-801 PHASE 1 COMBINATION DATA WITH KEYTRUDA (PEMBROLIZUMAB) IN MELANOMA EXPECTED BY END OF 2026

  • CYTOMX THERAPEUTICS INC - VARSETA-M PHASE 1 STUDY TO START IN Q1 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI